Hangzhou Singclean Medical Products Co., Ltd., established in March 2003 with registered capital of 20,000,000 RMB, is a national high and new technology enterprise integrating the R&D, production and sales of medical biomaterials. With well-qualified staff, thorough quality management system and first-class facilities, the company ensures the continuous production of medical devices and drug injection products of Class III that confirm to the laws and regulations of the State Food and Drug Administration (SFDA) and EU MDD. Sticking to a quality policy of "Quality First, Management Priority, Building a Harmonious Enterprise, and Creating the Singclean Brand", the company passed the ISO9001 quality management system certification and ISO13485 medical devices quality management system certification in 2007, and obtained in 2008 the Innovation Fund Certificate certified by the Ministry of Science and Technology with her MPH hemostatic microspheres project. The company obtained the certification of high and new technology enterprise of Hangzhou in 2007, of Zhejiang Province in 2008, of China in 2010, and her medical sodium hyaluronatethe gels passed the CE certification in 2011. In addition, the company set up a joint research center with Zhejiang University of Science and Technology, and has well established R & D cooperation relations with Zhejiang University, Donghua University and Zhejiang University of Technology, developing four series of new products with proprietary intellectual property rights, and with a variety of high-tech products to be developed cooperatively. The company also built an R & D platform for medical biomaterials that keeps up with the international level, and made major breakthrough in many key technologies such as those for stopping bleeding, anti-adhesion, and tissue engineering basic materials, with five patents obtained and a number of products applying for the patents.